Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

208
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
208
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Redox imbalance dictates dependence on GOT1 versus GOT2 for rod photoreceptor health during aging and stress.

Redox biology·2026
Same author

High-Density Lipoprotein Nanoparticles Delivering Liver X Receptor Agonist for the Treatment of Age-Related Macular Degeneration.

Molecular pharmaceutics·2026
Same author

Time to Revisit the Endophthalmitis Vitrectomy Study: Areas for Improvement in the Diagnosis and Treatment of Endophthalmitis.

Ophthalmology·2026
Same author

Comparative Cost Analysis of Pediatric and Adult Retinal Detachment Repairs Using Time-Driven Activity-Based Costing.

Journal of vitreoretinal diseases·2026
Same author

Multi-grader validation of the telemedicine retinopathy of prematurity severity score.

Scientific reports·2026
Same author

Redox imbalance dictates dependence on GOT1 versus GOT2 for rod photoreceptor health during aging and stress.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Mar 23, 2026

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate
05:58

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate

Published on: September 11, 2013

21.6K

Pharmacotherapies for Retinal Detachment.

Thomas J Wubben1, Cagri G Besirli1, David N Zacks1

  • 1Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan.

Ophthalmology
|April 5, 2016
PubMed
Summary

New pharmacotherapies are being explored to improve surgical success rates for retinal detachment, a leading cause of vision loss. These treatments aim to aid reattachment and protect photoreceptor cells from degeneration.

More Related Videos

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats
04:16

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Published on: March 7, 2025

1.3K
A Step by Step Protocol for Subretinal Surgery in Rabbits
12:31

A Step by Step Protocol for Subretinal Surgery in Rabbits

Published on: September 13, 2016

16.1K

Related Experiment Videos

Last Updated: Mar 23, 2026

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate
05:58

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate

Published on: September 11, 2013

21.6K
Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats
04:16

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Published on: March 7, 2025

1.3K
A Step by Step Protocol for Subretinal Surgery in Rabbits
12:31

A Step by Step Protocol for Subretinal Surgery in Rabbits

Published on: September 13, 2016

16.1K

Area of Science:

  • Ophthalmology
  • Retinal Diseases
  • Pharmacology

Background:

  • Retinal detachment is a significant cause of vision loss.
  • Current surgical treatments (vitrectomy, scleral buckle, pneumatic retinopexy) have limitations, with failure rates up to 20%.
  • Postoperative complications and photoreceptor degeneration impact visual outcomes.

Purpose of the Study:

  • To review potential pharmacotherapies for retinal detachment.
  • To explore agents that enhance surgical success rates.
  • To identify treatments that reduce redetachment and protect photoreceptors.

Main Methods:

  • Literature review of current and emerging pharmacotherapies.
  • Analysis of mechanisms targeting retinal reattachment and cell survival.
  • Discussion of strategies to mitigate proliferative vitreoretinopathy.

Main Results:

  • Pharmacotherapies show promise in aiding retinal reattachment.
  • Potential treatments can limit proliferative vitreoretinopathy, reducing redetachment rates.
  • Investigational drugs aim to protect photoreceptor cells from apoptosis.

Conclusions:

  • Pharmacotherapy represents a promising adjunct to surgical repair of retinal detachment.
  • Targeted drug delivery may improve visual outcomes and reduce complications.
  • Further research is needed to translate these findings into clinical practice.